Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LAM Pharmaceutical
Naples, Florida, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
LAM Pharmaceutical developed a proprietary IPM delivery system for transdermal and wound drug delivery and conducted preliminary clinical trials for slow healing diabetic ulcers before suspending its development activities and divesting its technology in 2008[1][5].
- Therapeutic areas
- EndocrinologyDermatology
- Modalities
- Hydrogel-based drug delivery therapySmall molecule
- Industry
- Biotech
02
Partnerships
Multinational corporate collaborator (name not disclosed as of early 2000s)[1]
Beyond the preview
Go deeper on LAM Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LAM Pharmaceutical.